Litigation Details for Astellas Pharma Inc. v. Sawai Pharmaceutical Co., Ltd. (D. Del. 2016)
✉ Email this page to a colleague
Astellas Pharma Inc. v. Sawai Pharmaceutical Co., Ltd. (D. Del. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-10-17 |
Court | District Court, D. Delaware | Date Terminated | 2019-09-13 |
Cause | 35:271 Patent Infringement | Assigned To | Joseph F. Bataillon |
Jury Demand | Defendant | Referred To | Christopher J. Burke |
Patents | 6,346,532; 7,342,117; 7,750,029; 7,982,049; 8,835,474; RE44,872 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Astellas Pharma Inc. v. Sawai Pharmaceutical Co., Ltd.
Details for Astellas Pharma Inc. v. Sawai Pharmaceutical Co., Ltd. (D. Del. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2017-01-16 | 16 | action for patent infringement of United States Patent Nos. 6,346,532 (“the '532 patent”), 7,342,117…claim of U.S. Patent Nos. 6,346,532 (“the '532 patent”), 7,342,117 (“the '117 patent”), 7,982,…, U.S. Patent No. 6,011,048, U.S. Patent No. 5,451,677, U.S. Patent No. 5,541,197, U.S. Patent No. 5,…'117 patent”), 7,982,049 (“the '049 patent”), 8,835,474 (“the '474 patent”), and RE44,872… and patentability of the '532 patent. A true and correct copy of the '532 patent is attached | External link to document | |
2016-10-17 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,346,532 B1; 7,342,117 B2; 7,982,049… 13 September 2019 1:16-cv-00954 830 Patent Defendant District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |